128 related articles for article (PubMed ID: 27176648)
1. Platelet-activating factor receptor activation promotes prostate cancer cell growth, invasion and metastasis via ERK1/2 pathway.
Ji W; Chen J; Mi Y; Wang G; Xu X; Wang W
Int J Oncol; 2016 Jul; 49(1):181-8. PubMed ID: 27176648
[TBL] [Abstract][Full Text] [Related]
2. Eotaxin-1 promotes prostate cancer cell invasion via activation of the CCR3-ERK pathway and upregulation of MMP-3 expression.
Zhu F; Liu P; Li J; Zhang Y
Oncol Rep; 2014 May; 31(5):2049-54. PubMed ID: 24604010
[TBL] [Abstract][Full Text] [Related]
3. Sulforaphane inhibits invasion by phosphorylating ERK1/2 to regulate E-cadherin and CD44v6 in human prostate cancer DU145 cells.
Peng X; Zhou Y; Tian H; Yang G; Li C; Geng Y; Wu S; Wu W
Oncol Rep; 2015 Sep; 34(3):1565-72. PubMed ID: 26134113
[TBL] [Abstract][Full Text] [Related]
4. Activation of platelet-activating factor receptor and pleiotropic effects on tyrosine phospho-EGFR/Src/FAK/paxillin in ovarian cancer.
Aponte M; Jiang W; Lakkis M; Li MJ; Edwards D; Albitar L; Vitonis A; Mok SC; Cramer DW; Ye B
Cancer Res; 2008 Jul; 68(14):5839-48. PubMed ID: 18632638
[TBL] [Abstract][Full Text] [Related]
5. Janus kinase 2 activation by the platelet-activating factor receptor (PAFR): roles of Tyk2 and PAFR C terminus.
Lukashova V; Chen Z; Duhé RJ; Rola-Pleszczynski M; Stanková J
J Immunol; 2003 Oct; 171(7):3794-800. PubMed ID: 14500680
[TBL] [Abstract][Full Text] [Related]
6. Human mesenchymal stem cells in the tumour microenvironment promote ovarian cancer progression: the role of platelet-activating factor.
Gao T; Yu Y; Cong Q; Wang Y; Sun M; Yao L; Xu C; Jiang W
BMC Cancer; 2018 Oct; 18(1):999. PubMed ID: 30340558
[TBL] [Abstract][Full Text] [Related]
7. [Effects and mechanisms of platelet-activating factor on the invasiveness of ovarian cancer cells in vitro].
Jiang W; Wang YS; Cong Q; Li MJ; Ye B; Xu CJ
Zhonghua Fu Chan Ke Za Zhi; 2011 Dec; 46(12):931-5. PubMed ID: 22333285
[TBL] [Abstract][Full Text] [Related]
8. Cancer-associated fibroblasts secrete FGF-1 to promote ovarian proliferation, migration, and invasion through the activation of FGF-1/FGFR4 signaling.
Sun Y; Fan X; Zhang Q; Shi X; Xu G; Zou C
Tumour Biol; 2017 Jul; 39(7):1010428317712592. PubMed ID: 28718374
[TBL] [Abstract][Full Text] [Related]
9. IL-17RB enhances thyroid cancer cell invasion and metastasis via ERK1/2 pathway-mediated MMP-9 expression.
Ren L; Xu Y; Liu C; Wang S; Qin G
Mol Immunol; 2017 Oct; 90():126-135. PubMed ID: 28715683
[TBL] [Abstract][Full Text] [Related]
10. Lysophosphatidylcholine acyltransferase1 overexpression promotes oral squamous cell carcinoma progression via enhanced biosynthesis of platelet-activating factor.
Shida-Sakazume T; Endo-Sakamoto Y; Unozawa M; Fukumoto C; Shimada K; Kasamatsu A; Ogawara K; Yokoe H; Shiiba M; Tanzawa H; Uzawa K
PLoS One; 2015; 10(3):e0120143. PubMed ID: 25803864
[TBL] [Abstract][Full Text] [Related]
11. SOX4 induces tumor invasion by targeting EMT-related pathway in prostate cancer.
Liu Y; Zeng S; Jiang X; Lai D; Su Z
Tumour Biol; 2017 May; 39(5):1010428317694539. PubMed ID: 28466783
[TBL] [Abstract][Full Text] [Related]
12. P2X7 receptor stimulates breast cancer cell invasion and migration via the AKT pathway.
Xia J; Yu X; Tang L; Li G; He T
Oncol Rep; 2015 Jul; 34(1):103-10. PubMed ID: 25976617
[TBL] [Abstract][Full Text] [Related]
13. Platelet-Activating Factor-Receptor Signaling Mediates Targeted Therapies-Induced Microvesicle Particles Release in Lung Cancer Cells.
Chauhan SJ; Thyagarajan A; Chen Y; Travers JB; Sahu RP
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33198218
[TBL] [Abstract][Full Text] [Related]
14. Trafficking, ubiquitination, and down-regulation of the human platelet-activating factor receptor.
Dupré DJ; Chen Z; Le Gouill C; Thériault C; Parent JL; Rola-Pleszczynski M; Stankova J
J Biol Chem; 2003 Nov; 278(48):48228-35. PubMed ID: 14500726
[TBL] [Abstract][Full Text] [Related]
15. Platelet-activating factor (PAF) positively auto-regulates the expression of human PAF receptor transcript 1 (leukocyte-type) through NF-kappa B.
Mutoh H; Ishii S; Izumi T; Kato S; Shimizu T
Biochem Biophys Res Commun; 1994 Dec; 205(2):1137-42. PubMed ID: 7802642
[TBL] [Abstract][Full Text] [Related]
16. Platelet activating factor-induced neuronal apoptosis is initiated independently of its G-protein coupled PAF receptor and is inhibited by the benzoate orsellinic acid.
Ryan SD; Harris CS; Mo F; Lee H; Hou ST; Bazan NG; Haddad PS; Arnason JT; Bennett SA
J Neurochem; 2007 Oct; 103(1):88-97. PubMed ID: 17877634
[TBL] [Abstract][Full Text] [Related]
17. Expression of platelet-activating factor receptor: a novel prognosticator in patients with hepatocellular carcinoma following hepatectomy.
Kitagawa D; Taketomi A; Kayashima H; Kuroda Y; Itoh S; Yamashita Y; Maehara Y
Oncology; 2007; 72(5-6):381-7. PubMed ID: 18187960
[TBL] [Abstract][Full Text] [Related]
18. Shikonin inhibits prostate cancer cells metastasis by reducing matrix metalloproteinase-2/-9 expression via AKT/mTOR and ROS/ERK1/2 pathways.
Chen Y; Zheng L; Liu J; Zhou Z; Cao X; Lv X; Chen F
Int Immunopharmacol; 2014 Aug; 21(2):447-55. PubMed ID: 24905636
[TBL] [Abstract][Full Text] [Related]
19. The expression of platelet-activating factor receptor modulates the cisplatin sensitivity of ovarian cancer cells: a novel target for combination therapy.
Yu Y; Zhang X; Hong S; Zhang M; Cai Q; Zhang M; Jiang W; Xu C
Br J Cancer; 2014 Jul; 111(3):515-24. PubMed ID: 24921917
[TBL] [Abstract][Full Text] [Related]
20. Modulation of Tumor-Associated Macrophages (TAM) Phenotype by Platelet-Activating Factor (PAF) Receptor.
da Silva Junior IA; Stone SC; Rossetti RM; Jancar S; Lepique AP
J Immunol Res; 2017; 2017():5482768. PubMed ID: 29445756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
